Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1146842


Argentina In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015


Description: Argentina In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Argentina In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Argentina

Scope

- The report provides information on the Argentine in vitro diagnostics market, broken down into detailed categories and segments including In Vitro Diagnostics Devices, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
- Market shares of all the key competitors including F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., and Siemens Medical Solutions, amongst others.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the in vitro diagnostics devices market in Argentina.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 In Vitro Diagnostics
3.2 Clinical Chemistry
3.2.1 Clinical Chemistry Rapid Tests & POC
3.2.2 Clinical Chemisty Analyzers
3.2.2.1 Automated Clinical Chemistry Analyzers
3.2.2.2 Semi-Automated Clinical Chemistry Analyzers
3.2.3 Electrolyte Chemistry Reagents
3.2.4 Enzyme Chemistry Reagents
3.2.5 Metabolite Chemistry Reagents
3.2.6 Urine Analysis
3.2.6.1 Urine Analyzer Reagents
3.2.6.2 Urine Analyzers
3.3 Genetic Testing
3.3.1 Acquired Gene or Chromosome Alterations
3.3.2 Inborn Gene or Chromosome Alterations
3.3.3 Other Genetic Tests
3.4 Haematology
3.4.1 Haematology Analyzers
3.4.2 Haematology Cell Counters
3.4.2.1 Differential Counters
3.4.2.2 Hemoglobinometers
3.4.3 Haematology Rapid Tests
3.4.3.1 Haemostasis Rapid Tests (Home Monitoring)
3.4.3.2 Rapid Haematology Tests (Point-Of-Care/Near Patient)
3.4.4 Haematology Reagents
3.4.4.1 Haematology Analyzer Reagents
3.4.4.2 Slide Stainers
3.4.5 Haemostasis
3.4.5.1 Coagulation Analyzers
3.4.5.2 Coagulation Factors
3.4.5.3 General Coagulation Tests
3.4.5.4 Platelet Factors
3.4.5.5 Special Coagulation Tests
3.4.6 Immunohaematology
3.4.6.1 ABO Typing
3.4.6.2 Antibody Detection
3.4.6.3 Rhesus Typing
3.5 Histology And Cytology
3.5.1 Cytology
3.5.1.1 Flow Cytometers
3.5.2 Histology
3.5.2.1 Monoclonal Antibodies
3.5.2.2 Tissue Typing Reagents
3.6 Immuno Chemistry
3.6.1 Disease Specific Immunochemistry
3.6.1.1 Auto-Immune Diseases
3.6.1.2 Cardiac Markers
3.6.1.3 Rheumatoid - Inflammatory Diseases Markers
3.6.1.4 Tumor markers
3.6.2 Drug Related Testing
3.6.2.1 Drugs of Abuse / Toxicology
3.6.2.2 Therapeutic Drug Monitoring
3.6.3 Endocrinology Tests
3.6.3.1 Fertility or Pregnancy Hormones
3.6.3.2 Individual and Specified Hormones
3.6.3.3 Thyroid Function Hormones
3.6.4 Immunochemistry Analyzers
3.6.4.1 Chemiluminescence Analyzers
3.6.4.2 ELISA Instruments
3.6.4.3 Immunofluorescence Analyzers
3.6.4.4 Radioimmunoassay Analyzers
3.6.5 Immunochemistry Rapid Tests
3.6.6 Organ Function Assays
3.6.7 Specific Proteins
3.7 Infectious Immunology
3.7.1 Bacteriology
3.7.2 Hepatitis Viruses
3.7.3 Other Virology
3.7.4 Retroviruses
3.8 Microbiology Culture
3.8.1 Bacterial Identification & Susceptibility Testing
3.8.2 Blood Culture
3.8.3 Immunological Culture Identification
3.8.4 Microbiology Analyzers
3.8.4.1 Automated Microbiology Analyzers
3.8.4.2 Semi-Automated Microbiology Analyzers
3.8.5 Mycobacteria Culture
3.8.6 Mycology Culture
3.8.7 Parasitology Culture
4 Healthcare Sector Review
5 Regulation System
5.1 Documents Required
5.2 Labeling Requirements
6 Pricing and Reimbursement
7 Distribution Structure
8 In Vitro Diagnostics In Argentina
8.1 In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), 2000-2015
8.2 In Vitro Diagnostics, Argentina, Company Share (2007-2008)
9 Clinical Chemistry In Argentina
9.1 Clinical Chemistry Overall Revenue (2000-2015)
9.1.1 Clinical Chemistry Analyzers Revenue (2000-2015)
9.1.2 Urine Analysis Revenue (2000-2015)
9.2 Clinical Chemistry Distribution Share (2007-2008)
9.3 Clinical Chemistry, Argentina, Company Share (2007-2008)
10 Genetic Testing In Argentina
10.1 Genetic Testing Overall Revenue (2000-2015)
10.2 Genetic Testing Distribution Share (2007-2008)
10.3 Genetic Testing, Argentina, Company Share (2007-2008)
11 Haematology In Argentina
11.1 Haematology Overall Revenue (2000-2015)
11.1.1 Haematology Reagents Revenue (2000-2015)
11.1.2 Immunohaematology Revenue (2000-2015)
11.1.3 Haemostasis Revenue (2000-2015)
11.1.4 Haematology Rapid Tests Revenue (2000-2015)
11.1.5 Haematology Cell Counters Revenue (2000-2015)
11.2 Haematology Distribution Share (2007-2008)
11.3 Haematology, Argentina, Company Share (2007-2008)
12 Histology and Cytology In Argentina
12.1 Histology and Cytology Overall Revenue (2000-2015)
12.1.1 Histology Revenue (2000-2015)
12.2 Histology And Cytology Distribution Share (2007-2008)
12.3 Histology And Cytology, Argentina, Company Share (2007-2008)
13 Immuno Chemistry In Argentina
13.1 Immuno Chemistry Overall Revenue (2000-2015)
13.1.1 Disease Specific Immunochemistry Revenue (2000-2015)
13.1.2 Drug Related Testing Revenue (2000-2015)
13.1.3 Endocrinology Tests Revenue (2000-2015)
13.1.4 Immunochemistry Analyzers Revenue (2000-2015)
13.2 Immuno Chemistry Distribution Share (2007-2008)
13.3 Immuno Chemistry, Argentina, Company Share (2007-2008)
14 Infectious Immunology In Argentina
14.1 Infectious Immunology Overall Revenue (2000-2015)
14.2 Infectious Immunology Distribution Share (2007-2008)
14.3 Infectious Immunology, Argentina, Company Share (2007-2008)
15 Microbiology Culture In Argentina
15.1 Microbiology Culture Overall Revenue (2000-2015)
15.1.1 Microbiology Analyzers Revenue (2000-2015)
15.2 Microbiology Culture Distribution Share (2007-2008)
15.3 Microbiology Culture, Argentina, Company Share (2007-2008)
16 Overview of Key Companies in Argentina In Vitro Diagnostics Market
16.1 Ventana Medical Systems, Inc.
16.1.1 Company Overview
16.2 Sysmex Corporation
16.2.1 Company Overview
16.2.2 Sysmex Corporation Pipeline Products
16.2.2.1 Sysmex Corporation Pipeline Products By Equipment Type
16.2.2.2 Sysmex Corporation Pipeline Products By Development Stage
16.2.2.3 Sysmex Corporation Pipeline Products By Therapy Area
16.2.2.4 Sysmex Corporation Pipeline Products By News Summary
16.3 Siemens Healthcare
16.3.1 Company Overview
16.4 Qiagen N.V.
16.4.1 Company Overview
16.4.2 Qiagen N.V. Pipeline Products
16.4.2.1 Qiagen N.V. Pipeline Products By Equipment Type
16.4.2.2 Qiagen N.V. Pipeline Products By Development Stage
16.4.2.3 Qiagen N.V. Pipeline Products By Therapy Area
16.4.2.4 Qiagen N.V. Pipeline Products By News Summary
16.5 Phadia AB
16.5.1 Company Overview
16.5.2 Phadia AB Pipeline Products
16.5.2.1 Phadia AB Pipeline Products By Equipment Type
16.5.2.2 Phadia AB Pipeline Products By Development Stage
16.5.2.3 Phadia AB Pipeline Products By Therapy Area
16.5.2.4 Phadia AB Pipeline Products By News Summary
16.6 Ortho-Clinical Diagnostics Inc.
16.6.1 Company Overview
16.6.2 Ortho-Clinical Diagnostics Inc. Pipeline Products
16.6.2.1 Ortho-Clinical Diagnostics Inc. Pipeline Products By Equipment Type
16.6.2.2 Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
16.6.2.3 Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
16.7 OLYMPUS CORPORATION
16.7.1 Company Overview
16.8 Inverness Medical Innovations, Inc.
16.8.1 Company Overview
16.8.2 Inverness Medical Innovations, Inc. Pipeline Products
16.8.2.1 Inverness Medical Innovations, Inc. Pipeline Products By Equipment Type
16.8.2.2 Inverness Medical Innovations, Inc. Pipeline Products By Development Stage
16.8.2.3 Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area
16.8.2.4 Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials
16.8.2.5 Inverness Medical Innovations, Inc. Pipeline Products By News Summary
16.9 Hologic, Inc.
16.9.1 Company Overview
16.9.2 Hologic, Inc. Pipeline Products
16.9.2.1 Hologic, Inc. Pipeline Products By Equipment Type
16.9.2.2 Hologic, Inc. Pipeline Products By Development Stage
16.9.2.3 Hologic, Inc. Pipeline Products By Therapy Area
16.9.2.4 Hologic, Inc. Pipeline Products By Clinical Trials
16.9.2.5 Hologic, Inc. Pipeline Products By News Summary
16.10 Gen-Probe Incorporated
16.10.1 Company Overview
16.10.2 Gen-Probe Incorporated Pipeline Products
16.10.2.1 Gen-Probe Incorporated Pipeline Products By Equipment Type
16.10.2.2 Gen-Probe Incorporated Pipeline Products By Development Stage
16.10.2.3 Gen-Probe Incorporated Pipeline Products By Therapy Area
16.10.2.4 Gen-Probe Incorporated Pipeline Products By Clinical Trials
16.10.2.5 Gen-Probe Incorporated Pipeline Products By News Summary
16.11 F. Hoffmann-La Roche Ltd.
16.11.1 Company Overview
16.12 DiaSorin S.p.A
16.12.1 Company Overview
16.12.2 DiaSorin S.p.A Pipeline Products
16.12.2.1 DiaSorin S.p.A Pipeline Products By Equipment Type
16.12.2.2 DiaSorin S.p.A Pipeline Products By Development Stage
16.12.2.3 DiaSorin S.p.A Pipeline Products By Therapy Area
16.13 Dade Behring Holdings, Inc.
16.13.1 Company Overview
16.14 Bio-Rad Laboratories, Inc.
16.14.1 Company Overview
16.15 bioMerieux S.A.
16.15.1 Company Overview
16.16 Becton, Dickinson and Company
16.16.1 Company Overview
16.16.2 Becton, Dickinson and Company Pipeline Products
16.16.2.1 Becton, Dickinson and Company Pipeline Products By Equipment Type
16.16.2.2 Becton, Dickinson and Company Pipeline Products By Development Stage
16.16.2.3 Becton, Dickinson and Company Pipeline Products By Therapy Area
16.16.2.4 Becton, Dickinson and Company Pipeline Products By Clinical Trials
16.16.2.5 Becton, Dickinson and Company Pipeline Products By News Summary
16.17 Beckman Coulter, Inc.
16.17.1 Company Overview
16.17.2 Beckman Coulter, Inc. Pipeline Products
16.17.2.1 Beckman Coulter, Inc. Pipeline Products By Equipment Type
16.17.2.2 Beckman Coulter, Inc. Pipeline Products By Development Stage
16.17.2.3 Beckman Coulter, Inc. Pipeline Products By Therapy Area
16.17.2.4 Beckman Coulter, Inc. Pipeline Products By News Summary
16.18 Abbott Laboratories
16.18.1 Company Overview
16.18.2 Abbott Laboratories Pipeline Products
16.18.2.1 Abbott Laboratories Pipeline Products By Equipment Type
16.18.2.2 Abbott Laboratories Pipeline Products By Development Stage
16.18.2.3 Abbott Laboratories Pipeline Products By Therapy Area
16.19 Wiener Laboratorios S.A.I.C.
16.19.1 Company Overview
17 Recent Developments
17.1 Strategy And Business Planning
17.1.1 Apr 07, 2009: Covance Announces New Clinical Development Offices In Chile, Peru And Expands Argentina Office
17.2 Other Significant Developments
17.2.1 Jan 27, 2009: Meridian Bioscience Signs Distribution Agreements In Australia And Argentina
18 Appendix
18.1 Global Markets Direct Research Methodology
18.2 Secondary Research
18.3 Primary Research
18.4 Models
18.5 Forecasts
18.6 Expert Panel Validation
18.7 Currency Conversion
18.8 Contact Us
18.9 Disclaimer

Executive Summary

1.1 List of Tables
Table 1: Healthcare Expenditure, Argentina, 2000-2007 25
Table 2: In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), 2000-2015 31
Table 3: In Vitro Diagnostics, Argentina, Cross-Category Analysis, 2000-2015 32
Table 4: In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), Historic, 2000-2008 34
Table 5: In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), Forecast, 2008-2015 36
Table 6: In Vitro Diagnostics, Argentina, Company Share by Revenue ($ mn), 2007-2008 37
Table 7: Clinical Chemistry, Argentina, Revenue ($ mn) by Segment, Historic, 2000-2008 39
Table 8: Clinical Chemistry, Argentina, Revenue ($ mn) by Segment, Forecast, 2008-2015 41
Table 9: Clinical Chemistry Analyzers, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 42
Table 10: Clinical Chemistry Analyzers, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 43
Table 11: Urine Analysis, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 44
Table 12: Urine Analysis, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 45
Table 13: Clinical Chemistry, Argentina, Distribution Share by Revenue ($mn), 2007-2008 46
Table 14: Clinical Chemistry, Argentina, Company Share by Revenue ($ mn), 2007-2008 47
Table 15: Genetic Testing, Argentina, Revenue ($ mn) by Segment, Historic, 2000-2008 48
Table 16: Genetic Testing, Argentina, Revenue ($ mn) by Segment, Forecast, 2008-2015 49
Table 17: Genetic Testing, Argentina, Distribution Share by Revenue ($mn), 2007-2008 50
Table 18: Genetic Testing, Argentina, Company Share by Revenue ($ mn), 2007-2008 51
Table 19: Haematology, Argentina, Revenue ($ mn) by Segment, Historic, 2000-2008 53
Table 20: Haematology, Argentina, Revenue ($ mn) by Segment, Forecast, 2008-2015 55
Table 21: Haematology Reagents, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 56
Table 22: Haematology Reagents, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 57
Table 23: Immunohaematology, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 58
Table 24: Immunohaematology, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 59
Table 25: Haemostasis, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 61
Table 26: Haemostasis, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 63
Table 27: Haematology Rapid Tests, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 64
Table 28: Haematology Rapid Tests, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 65
Table 29: Haematology Cell Counters, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 66
Table 30: Haematology Cell Counters, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 67
Table 31: Haematology, Argentina, Distribution Share by Revenue ($mn), 2007-2008 68
Table 32: Haematology, Argentina, Company Share by Revenue ($ mn), 2007-2008 69
Table 33: Histology and Cytology, Argentina, Revenue ($ mn) by Segment, Historic, 2000-2008 70
Table 34: Histology And Cytology, Argentina, Revenue ($ mn) by Segment, Forecast, 2008-2015 71
Table 35: Histology, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 72
Table 36: Histology, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 73
Table 37: Histology And Cytology, Argentina, Distribution Share by Revenue ($mn), 2007-2008 74
Table 38: Histology And Cytology, Argentina, Company Share by Revenue ($ mn), 2007-2008 75
Table 39: Immuno Chemistry, Argentina, Revenue ($ mn) by Segment, Historic, 2000-2008 77
Table 40: Immuno Chemistry, Argentina, Revenue ($ mn) by Segment, Forecast, 2008-2015 79
Table 41: Disease Specific Immunochemistry, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 81
Table 42: Disease Specific Immunochemistry, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 83
Table 43: Drug Related Testing, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 84
Table 44: Drug Related Testing, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 85
Table 45: Endocrinology Tests, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 86
Table 46: Endocrinology Tests, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 87
Table 47: Immunochemistry Analyzers, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 89
Table 48: Immunochemistry Analyzers, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 91
Table 49: Immuno Chemistry, Argentina, Distribution Share by Revenue ($mn), 2007-2008 92
Table 50: Immuno Chemistry, Argentina, Company Share by Revenue ($ mn), 2007-2008 94
Table 51: Infectious Immunology, Argentina, Revenue ($ mn) by Segment, Historic, 2000-2008 96
Table 52: Infectious Immunology, Argentina, Revenue ($ mn) by Segment, Forecast, 2008-2015 98
Table 53: Infectious Immunology, Argentina, Distribution Share by Revenue ($mn), 2007-2008 99
Table 54: Infectious Immunology, Argentina, Company Share by Revenue ($ mn), 2007-2008 101
Table 55: Microbiology Culture, Argentina, Revenue ($ mn) by Segment, Historic, 2000-2008 103
Table 56: Microbiology Culture, Argentina, Revenue ($ mn) by Segment, Forecast, 2008-2015 105
Table 57: Microbiology Analyzers, Argentina, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 106
Table 58: Microbiology Analyzers, Argentina, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 107
Table 59: Microbiology Culture, Argentina, Distribution Share by Revenue ($mn), 2007-2008 108
Table 60: Microbiology Culture, Argentina, Company Share by Revenue ($ mn), 2007-2008 109
Table 61: Sysmex Corporation Pipeline Products by Equipment Type 110
Table 62: Sysmex Corporation Pipeline Products By Development Stage 110
Table 63: Sysmex Corporation Pipeline Products By Therapy Area 111
Table 64: Sysmex Corporation Pipeline Products By News Summary 111
Table 65: Qiagen N.V. Pipeline Products by Equipment Type 113
Table 66: Qiagen N.V. Pipeline Products By Development Stage 113
Table 67: Qiagen N.V. Pipeline Products By Therapy Area 114
Table 68: Qiagen N.V. Pipeline Products By News Summary 114
Table 69: Phadia AB Pipeline Products by Equipment Type 115
Table 70: Phadia AB Pipeline Products By Development Stage 115
Table 71: Phadia AB Pipeline Products By Therapy Area 116
Table 72: Phadia AB Pipeline Products By News Summary 116
Table 73: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 117
Table 74: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 118
Table 75: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 118
Table 76: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type 120
Table 77: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage 120
Table 78: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area 121
Table 79: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials 121
Table 80: Inverness Medical Innovations, Inc. Pipeline Products By News Summary 121
Table 81: Hologic, Inc. Pipeline Products by Equipment Type 122
Table 82: Hologic, Inc. Pipeline Products By Development Stage 123
Table 83: Hologic, Inc. Pipeline Products By Therapy Area 123
Table 84: Hologic, Inc. Pipeline Products By Clinical Trials 123
Table 85: Hologic, Inc. Pipeline Products By News Summary 124
Table 86: Gen-Probe Incorporated Pipeline Products by Equipment Type 125
Table 87: Gen-Probe Incorporated Pipeline Products By Development Stage 126
Table 88: Gen-Probe Incorporated Pipeline Products By Therapy Area 126
Table 89: Gen-Probe Incorporated Pipeline Products By Clinical Trials 126
Table 90: Gen-Probe Incorporated Pipeline Products By News Summary 127
Table 91: DiaSorin S.p.A Pipeline Products by Equipment Type 129
Table 92: DiaSorin S.p.A Pipeline Products By Development Stage 129
Table 93: DiaSorin S.p.A Pipeline Products By Therapy Area 129
Table 94: Becton, Dickinson and Company Pipeline Products by Equipment Type 132
Table 95: Becton, Dickinson and Company Pipeline Products By Development Stage 133
Table 96: Becton, Dickinson and Company Pipeline Products By Therapy Area 133
Table 97: Becton, Dickinson and Company Pipeline Products By Clinical Trials 134
Table 98: Becton, Dickinson and Company Pipeline Products By News Summary 134
Table 99: Beckman Coulter, Inc. Pipeline Products by Equipment Type 135
Table 100: Beckman Coulter, Inc. Pipeline Products By Development Stage 136
Table 101: Beckman Coulter, Inc. Pipeline Products By Therapy Area 137
Table 102: Beckman Coulter, Inc. Pipeline Products By News Summary 137
Table 103: Abbott Laboratories Pipeline Products by Equipment Type 138
Table 104: Abbott Laboratories Pipeline Products By Development Stage 138
Table 105: Abbott Laboratories Pipeline Products By Therapy Area 138
Table 106: USD to Local Currency, Average Exchange Rate 2008 145


Companies Mentioned Ventana Medical Systems, Inc. Sysmex Corporation Siemens Healthcare Qiagen N.V. Phadia AB Ortho-Clinical Diagnostics Inc. OLYMPUS CORPORATION Inverness Medical Innovations, Inc. Hologic, Inc. Gen-Probe Incorporated F. Hoffmann-La Roche Ltd. DiaSorin S.p.A Dade Behring Holdings, Inc. Bio-Rad Laboratories, Inc. bioMerieux S.A. Becton, Dickinson and Company Beckman Coulter, Inc. Abbott Laboratories Wiener Laboratorios S.A.I.C.


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1146842

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 01:38:27
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Argentina In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Web Address:
http://www.researchandmarkets.com/reports/1146842
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €1,911.00
Electronic (PDF) - Site License €3,821.00
Electronic (PDF) - Enterprisewide €5,732.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 01:38:27

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)